Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
Incyte Corporation
M.D. Anderson Cancer Center
Compugen Ltd
Purple Biotech Ltd.
Eli Lilly and Company
Astellas Pharma Inc
Compugen Ltd
Memorial Sloan Kettering Cancer Center
Herlev Hospital
Incyte Corporation
Five Prime Therapeutics, Inc.
AbbVie